This uniform and structured reclassification, incorporating the largest dataset of variants implicated in <i>FOXL2</i>-associated disease so far, will improve both the diagnosis as well as genetic counselling for individuals with BPES. This evidence concerns the gene FOXL2 and blepharophimosis, ptosis, and epicanthus inversus syndrome.